Thursday, 19th October 12th Australian Peptide Conference 2017
Breakfast
7:30AM - 8:30AM
Thursday, 19th October
View Restaurant and Bar
Registration
8:00AM - 7:15PM
Thursday, 19th October
Pre-Conference Terrace
Session 11 - Design
8:30AM - 10:30AM
Thursday, 19th October
Macquarie Conference Centre
Chairs: Ian Smith & Manjunatha Kini
- From rational to computational peptide design and back again - Dek Woolfson
- De Novo Design of Constrained and Sequence-Independent Peptide Scaffolds with Topologically-Formidable Disulfide Connectivities - Chuanliu Wu
- Structural design of alpha-helix mimetics to target and disrupt estrogen receptor-coregulator interactions for treating breast cancer - Jung-Mo Ahn
- Molecular Design of Stable and Potent Peptide Modulators for Class B GPCRs - Krishna Kumar
- Genetically-Encoded Chemically-Modified Peptides - Ratmir Derda
Morning Tea
10:30AM - 11:00AM
Thursday, 19th October
Pre-Conference Terrace
Session 12 - Advancing technologies / Nano
11:00AM - 1:00PM
Thursday, 19th October
Macquarie Conference Centre
Chairs: Ed Nice & Gilles Subra
- New multi-functional peptide-based materials - Mark Del Borgo
- Macrocyclic peptide drug discovery through genetic code reprogramming - Toby Passioura
- Database Searchable Proteome-derived Peptide Libraries for characterising cleavage site PTM specificities - Christopher M Overall
- Accurate control of dual receptor-engineered T cell activity through a bifunctional molecule - Hanmei Xu
- Nanotechnology-based delivery systems for improving the use of peptides - Uracha Ruktanonchai
Lunch
1:00PM - 2:00PM
Thursday, 19th October
View Restaurant and Bar
Session 13 - Towards the Clinic
4:00PM - 6:05PM
Thursday, 19th October
Macquarie Conference Centre
Chairs: Max Cryle & Jim Olson
- PTG-100, an oral peptide antagonist of α4β7 integrin, for the treatment of inflammatory bowel disease - Greg Bourne
- Constrained and biased 11 amino acid glucagon-like peptide-1 receptor agonists - David A Griffith
- Moving peptides to the clinic: improving properties to treat patients - Alleyn T Plowright
- Development of a potent D-protein inhibitor of VEGF-A with reduced immunogenicity and a longer half-life - Dana Ault-Riche
- Guanylate Cyclase C: A Target for the Treatment of Functional Intestinal Disorders - Mark Currie
Closing Session 14
6:10PM - 7:15PM
Thursday, 19th October
Macquarie Conference Centre
Chair: Norelle Daly
Conference Dinner
7:30PM - 10:30PM
Thursday, 19th October
View Restaurant and Bar
Sponsored by:
